
TENX Valuation
Tenax Therapeutics Inc
- Overview
- Forecast
- Valuation
- Earnings
TENX Relative Valuation
TENX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, TENX is overvalued; if below, it's undervalued.
Historical Valuation
Tenax Therapeutics Inc (TENX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.70. The fair price of Tenax Therapeutics Inc (TENX) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price:6.05
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
2.19
P/B
Median3y
0.93
Median5y
2.96
-6.95
FCF Yield
Median3y
-123.86
Median5y
-92.26
Competitors Valuation Multiple
The average P/S ratio for TENX's competitors is 1.09, providing a benchmark for relative valuation. Tenax Therapeutics Inc Corp (TENX) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

INAB
IN8bio Inc
2.410
USD
-2.03%

DRCT
Direct Digital Holdings Inc
0.541
USD
-1.82%

INHD
Inno Holdings Inc
1.420
USD
-1.39%

SFHG
Samfine Creation Holdings Group Ltd
0.777
USD
-13.57%

CDIO
Cardio Diagnostics Holdings Inc
4.580
USD
+3.85%

NWGL
Nature Wood Group Ltd
1.030
USD
-0.96%

SNTI
Senti Biosciences Inc
1.990
USD
-2.93%

ELBM
Electra Battery Materials Corp
1.295
USD
0.00%

SHFS
SHF Holdings Inc
3.310
USD
0.00%

ERNA
Ernexa Therapeutics Inc
2.100
USD
-4.98%
FAQ

Is Tenax Therapeutics Inc (TENX) currently overvalued or undervalued?
Tenax Therapeutics Inc (TENX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.70. The fair price of Tenax Therapeutics Inc (TENX) is between NaN to NaN according to relative valuation methord.

What is Tenax Therapeutics Inc (TENX) fair value?

How does TENX's valuation metrics compare to the industry average?

What is the current P/B ratio for Tenax Therapeutics Inc (TENX) as of Jul 25 2025?

What is the current FCF Yield for Tenax Therapeutics Inc (TENX) as of Jul 25 2025?

What is the current Forward P/E ratio for Tenax Therapeutics Inc (TENX) as of Jul 25 2025?
